Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-09-11
2007-09-11
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C514S413000, C514S947000
Reexamination Certificate
active
09903665
ABSTRACT:
An analgesic/anti-inflammatory pharmaceutical dosage form which comprises an effective amount of an active ingredient selected from the group consisting of racemic 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, optically active forms thereof and pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable excipient or diluent, said dosage form being an intranasally administrable dosage form.
REFERENCES:
patent: 4089569 (1978-05-01), Muchowski
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4478822 (1984-10-01), Haslam
patent: 4778810 (1988-10-01), Wenig et al.
patent: 4885287 (1989-12-01), Hussain
patent: 4919939 (1990-04-01), Baker
patent: 4943587 (1990-07-01), Cetenko et al.
patent: 4973596 (1990-11-01), Cohen
patent: 4994439 (1991-02-01), Longenecker et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5091182 (1992-02-01), Ong et al.
patent: 5122127 (1992-06-01), Stanley
patent: 5143731 (1992-09-01), Viegas et al.
patent: 5855907 (1999-01-01), Peyman
patent: 6090368 (2000-07-01), Zia et al.
patent: 03-072433 (1991-03-01), None
patent: WO88/004929 (1988-07-01), None
patent: WO-90/001322 (1990-02-01), None
patent: WO90/07333 (1990-07-01), None
JP 03-072433, Foamy Aerosol Preparation, Patent Abstracts of Japan, Mar. 27, 1991, abstract.
Rubin, M.D. et al Comparison Long-Term Safety of Ketorolac Tromethamine and Aspirin in the Treatment of Chronic Pain.Pharmacotherapy (1990) 10(6pt. 2) pp.106S-110S.
Santus et al., Nasal Formulations of Ketoroloac Tromethamine Technological Evaluation-Bioavailability and Tolerability in Rabbits, IL Farmaco, 48 (12), 1709-1723; 1993.
Mroszczak, E. J., et al., Ketorolac Tromethamine Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics in Animals and Humans, Drug Metab. Dispos., 15 (5):618-626, 1987.
Chien, Y.W. and Chang, S.F., Historical Development of Transnasal Systemic Medications; In:Transnasal Systemic Medications, edited by Y.W. Chien, Elsevier Science Publishers B.V., Amsterdam, 1985.
Buckley, M.M.T.,Drugs39:86-109, 1990.
Yu, D.,Pharmaceutical Research 5:457-462, 1988.
Rooks, W.H.Drugs Exptl. Clin. Res.11:479-492, 1985.
O'Hara, D.A.,Clin. Pharmacol. Ther.41:556-561, 1987.
Illum, L.,International Journal of Pharmaceutics 39:189-199, 1987.
Morimoto, K.,J. Pharm. Pharmacol.37:134-136, 1985.
Hirai, S.,International Journal of Pharmaceutics 9:165-172, 1981.
Pennington, A.K.,International Journal of Pharmaceutics 43:221-224, 1988.
DePonti, R.,Drug Development and Industrial Pharmacy 17:1419-1436, 1991.
Bilato Ettore
Bottoni Giuseppe
Santus Giancarlo
Krass Frederick
Recordati S.A.
LandOfFree
Therapeutic compositions for intranasal administration which... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compositions for intranasal administration which..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions for intranasal administration which... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3749425